In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 8, 2000, Pages 2225-2229

  Boucher, Helen W ^a,b   Wennersten, Christine B ^a   Eliopoulos, George M ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; GLYCYLCYCLINE DERIVATIVE; MINOCYCLINE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; TETRACYCLINE;

EID: 0033926236     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.8.2225-2229.2000     Document Type: Article

References (16)

1. Centers for Disease Control and Prevention. 1993. Nosocomial enterococci resistant to vancomycin - United States, 1989-1993. Morb. Mortal. Wkly. Rep. 42:597-599.
2. Collins, L. A., G. J. Malanoski, G. M. Eliopoulos, C. B. Wennersten, M. J. Ferraro, and R. C. Moellering, Jr. 1993. In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrob. Agents Chemother. 37:598-601.
3. Edmond, M. B., J. F. Ober, J. D. Dawson, D. L. Weinbaum, and R. P. Wenzel. 1996. Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin. Infect. Dis. 23:1234-1239.
4. Eliopoulos, G. M., A. Gardella, and R. C. Moellering, Jr. 1982. In vitro activity of Sch 29482 in comparison with other oral antibiotics. J. Antimicrob. Chemother. 9(Suppl. C):143-152.
5. Eliopoulos, G. M., C. B. Wennersten, G. Cole, and R. C. Moellering. 1994. In vitro activities of two glycylcyclines against gram-positive bacteria. Antimicrob. Agents Chemother. 38:534-541.
6. Eliopoulos, G. M. 1997. Vancomycin-resistant enterococci. Infect. Dis. Clin. N. Am. 11:851-865.
7. Fridkin, S. K., J. R. Edwards, S. C. Pichette, E. R. Pryor, J. E. McGowan, Jr., F. C. Tenover, D. H. Culver, and R. P. Gaynes. 1999. Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin. Infect. Dis. 28:1119-1125.
8. Gold, H. S., and R. C. Moellering, Jr. 1996. Antimicrobial-drug resistance. N. Engl. J. Med. 335:1445-1453.
9. Jensen, A. G., C. H. Wachmann, K. B. Poulsen, F. Espersen, J. Scheibel, P. Pkinhoj, and N. Frimodt-Moeller. 1999. Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch. Intern. Med. 159:1437-1444.
10. Landman, D., M. Chockalingam, and J. M. Quale. 1999. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin. Infect. Dis. 28:1062-1066.
11. Moellering, R. C., Jr. 1998. Problems with antimicrobial resistance in grampositive cocci. Clin. Infect. Dis. 26:1177-1178.
12. National Committee for Clinical Laboratory Standards, 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. Ostrowsky, B. E., L. Venkataraman, E. M. C. D'Agata, H. S. Gold, P. C. DeGirolami, and M. H. Samore, 1999. Vancomycin-resistant enterococci in intensive care units. Arch. Intern. Med. 159:1467-1472.
14. Petersen, P. J., N. V. Jacobus, W. J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
15. Rasmussen, B. A., Y. Gluzman, and F. P. Tally. 1994. Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines. Antimicrob. Agents Chemother. 38:1658-1660.
16. Rhinehart, E., N. E. Smith, C. Wennersten, E. Gorss, J. Freeman, G. M. Eliopoulos, R. C. Moellering, Jr., and D. A. Goldmann. 1990. Rapid dissemination of β-lactamase-producing aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N. Engl. J. Med. 323:1814-1818.